. Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-␣ or -␤: an echocardiograph study. Am J Physiol Endocrinol Metab 283: E428-E435, 2002; 10.1152/ajpendo.00019. 2002.-We investigated the effect of thyroid hormone (TH) receptor (TR)␣ and -␤ isoforms in TH action in the heart. Noninvasive echocardiographic measurements were made in mice homozygous for disruption of TR␣ (TR␣ 0/0 ) or TR␤ (TR␤ Ϫ/Ϫ ). Mice were studied at baseline, 4 wk after TH deprivation (using a low-iodine diet containing propylthiouracil), and after 4-wk treatment with TH. Baseline heart rates (HR) were similar in wild-type (WT) and TR␣ 0/0 mice but were greater in TR␤ Ϫ/Ϫ mice. With TH deprivation, HR decreased 49% in WT and 37% in TR␤ Ϫ/Ϫ mice and decreased only 5% in TR␣ 0/0 mice from baseline, whereas HR increased in all genotypes with TH treatment. Cardiac output (CO) and cardiac index (CI) in WT mice decreased (Ϫ31 and Ϫ32%, respectively) with TH deprivation and increased (ϩ69 and ϩ35%, respectively) with TH treatment. The effects of CO and CI were blunted with TH withdrawal in both TR␣ 0/0 (ϩ8 and Ϫ2%, respectively) and TR␤ Ϫ/Ϫ mice (Ϫ17 and Ϫ18%, respectively). Treatment with TH resulted in a 64% increase in LV mass in WT and a 44% increase in TR␣ 0/0 mice but only a 6% increase in TR␤ Ϫ/Ϫ mice (ANOVA P Ͻ 0.05). Taken together, these data suggest that TR␣ and TR␤ play different roles in the physiology of TH action on the heart. left ventricular mass; thyrotropin; cardiac index; cardiac output; shortening fraction THYROID HORMONE (TH) exerts a profound effect on the chronotropic and ionotropic function of the heart (25, 28). TH deficiency results in systolic and diastolic dysfunction with reduction in heart rate and force of contraction and an increase in cardiac relaxation (18, 23). The molecular basis for the negative ionotropic consequences of hypothyroidism can be linked to decreased expression of the sarcoplasmic reticulum Ca 2ϩ ATPase gene (42) and myosin heavy chain (MHC)␣ and increase in MHC␤ (27, 42) . The latter results in decreased speed of systolic contraction due to the increased expression of myosin V3, which has a lower ATPase activity (2, 44). The molecular basis for the ionotropic effect seen in hypothyroidism, namely the bradycardia, is related to decreased expression of the hyperpolarization-activated, cyclic nucleotide-gated genes 2 or 4, which are specific targets of the TH receptor (TR)␣ gene (19).
left ventricular mass; thyrotropin; cardiac index; cardiac output; shortening fraction THYROID HORMONE (TH) exerts a profound effect on the chronotropic and ionotropic function of the heart (25, 28) . TH deficiency results in systolic and diastolic dysfunction with reduction in heart rate and force of contraction and an increase in cardiac relaxation (18, 23) . The molecular basis for the negative ionotropic consequences of hypothyroidism can be linked to decreased expression of the sarcoplasmic reticulum Ca 2ϩ ATPase gene (42) and myosin heavy chain (MHC)␣ and increase in MHC␤ (27, 42) . The latter results in decreased speed of systolic contraction due to the increased expression of myosin V3, which has a lower ATPase activity (2, 44) . The molecular basis for the ionotropic effect seen in hypothyroidism, namely the bradycardia, is related to decreased expression of the hyperpolarization-activated, cyclic nucleotide-gated genes 2 or 4, which are specific targets of the TH receptor (TR)␣ gene (19) .
TH action is mediated by its interaction with specific nuclear TRs functioning as ligand-dependent transcription factors that modulate the expression of target genes (30, 33) . The two TR genes TR␣ and TR␤ have substantial structural and sequence similarities. Each generates multiple TR proteins by alternative splicing (␣ 1 and ␣ 2 ; ␤ 1 , ␤ 2 , and ␤ 3 ) or alternative start sites (⌬␣ 1 , ⌬␣ 2 , revErb). TR␣ 2 binds to DNA, but, due to a sequence difference at the ligand-binding site, it does not bind TH and thus does not function as a TR proper (35) . The relative expression of TR genes and the distribution of their products vary among tissues and during different stages of development (20, 31, 46) . Furthermore, an internal promoter, located within intron 7 of the TR␣ gene, is responsible for the expression, in mice, of truncated isoforms of TR␣ 1 and TR␣ 2 , (TR⌬␣ 1 and TR⌬␣ 2 ) containing the carboxy-terminal segment of the molecule. These additional products of the TR␣ gene may play a role in downregulation of transcriptional activity (5, 17, 40) . TR␣ 1 and TR␣ 2 are the major isoforms of TR expressed in the heart (24) . Although TR␤ 1 is expressed at low levels (10), TR␤ 2 is also expressed (43) . The use of mice with disruption of either the TR␤ or TR␣ gene has led to the conclusion that the effect of L-triiodothyronine (L-T 3 ) on the heart is mediated predominantly by TR␣ (19, 21, 22, 38, 48) . These studies have primarily examined the effect of TH deprivation and have not examined the effect of long-term TH excess.
The purpose of the present study was to examine the contribution that both TR␤ and TR␣ make in the presence of TH withdrawal and TH treatment on the chronotropic and ionotropic effect on the heart in vivo as determined by echocardiographic parameters. Echo-cardiography uniquely allows the study of sequential changes in TH action over time in the same animals. We have confirmed that chronotropic effects of TH on the heart are primarily TR␣ dependent. Furthermore, we have demonstrated that in an intact animal the action of TH on the heart is both TR␤ and TR␣ dependent.
METHODS
Mice. Mice were weaned on the 4th wk after birth and fed a rodent diet (no. 5053; Lab Diet, Brentwood, MO) containing 0.53 ppm iodine and were given tap water ad libitum. They were housed three to five mice per cage in an environment of controlled 19°C temperature and 12-h alternating dark-artificial light cycles. All animal experiments were performed according to approved protocols at the University of Chicago by the Institutional Animal Care and Use Committee.
Male mice were 50-90 days old at the time of initial blood sampling. Three hundred microliters of blood were obtained by retroorbital vein puncture under light methoxyflurane (Pitman Moore, Mundelein, IL) anesthesia. Bleeding was generally done between 0900 and 1200. Serum was separated by centrifugation and stored at Ϫ20°C until analyzed.
The TR␤ knockout mice were produced by insertion of the LacZ-NeoR cassette downstream of the splice site in exon 4, eliminating the expression of the DNA and ligand-binding domains of TR␤ 1 and TR␤2 (TR␤ Ϫ/Ϫ ) (16) . The TR␣ knockout mouse was produced by insertion of the LacZ-NeoR cassette downstream of exon 3 and replacing exons 5-7, thus effectively abolishing not only the generation of full TR␣ 1 and TR␣2 transcripts but also that of TR⌬␣1 or TR⌬␣2 (TR␣ 0/0 ) by removal of the transcription start point at intron 7 (17) . The gene sequence for rev-erbA-␣ protein encoded by the opposite strands for the TR␣ (45) remains intact. In both sets of mice, the recombinant ES cells were derived from 129sv mice and were implanted into C57BL/6 recipient blastocysts. C57BL/6 mice were mated to each chimeric mouse and then backcrossed three to four times into the same strain, thereby diluting the 129sv background. The TR␣ 0/0 and TR␤ Ϫ/Ϫ mice were crossed for greater than five generations to select wildtype mice that had similar backgrounds.
Induction of hypothyroidism and treatment with TH. TH deficiency was induced in 10 male mice of each type (wild type, TR␣ 0/0 , and TR␤ Ϫ/Ϫ ) with a low-iodine diet containing 0.15% 5-propyl-2-thiouracil (PTU) for 4 wk. Blood samples were obtained from the retroorbital vein after recording of echocardiograms as described in Echocardiograms. The same mice were then placed for 4 wk on L-thyroxine (L-T4) contained in the drinking water (2 g/ml). Mice drank ϳ5 ml/ day, resulting in a total dose of 10 g L-T4 ⅐ day Ϫ1 ⅐ mouse Ϫ1 . Hormone measurements. Serum total T4 was measured by coated-tube RIAs (DPC; Diagnostic Products, Los Angeles, CA) with 25 l of serum. The sensitivity of this assay is 0.2 g T 4/dl (2.6 nmol/l). The interassay coefficients of variation were 5.4, 4.2, and 3.6% at 3.8, 9.4, and 13.7 g/dl T4, respectively.
Serum TSH was measured in 50 l of serum by use of a sensitive, heterologous, disequilibrium, double-antibody precipitation RIA, as previously described (41) . The sensitivity of this assay was 5-10 mU/l. The intra-assay and interassay coefficients of variation were, respectively, 16 and 27% at 20 mU/l, 6.3 and 8.2% at 200 mU/l, 5.4 and 9.8% at 850 mU/l, and 10 and 24% at 2,000 mU/l. Samples containing Ͼ1,000 and Ͼ10,000 mU thyroid-stimulating hormone (TSH)/l were diluted 10-to 100-fold, respectively, with zero TSH mouse serum obtained from wild-type mice treated with a suppressive dose of T 4 (41) .
Ventricular weight. At the end of the 4 wk of L-T4 treatment and after completion of the final echocardiographic recording, mice were killed and their hearts excised. The left ventricles were separated and carefully isolated by trimming the atria and the valves, blotted of excess fluid, and were weighed on a Mettler Balance (model no. AG245) with an accuracy of Ϯ 0.01 mg.
Echocardiograms. For animal preparation, 30 mice were studied, including 10 wild-type, 10 TR␤ Ϫ/Ϫ , and 10 TR␣ 0/0 mice, as described. Before acquisition of cardiac ultrasound recordings, anesthesia was induced by administering chloral hydrate (500 mg/5 ml; Pennex Pharmaceutical) intraperitoneally in a 4% solution in PBS at a dose of 0.4 mg/g mouse. Animals were then secured to a custom-made waterbed in a shallow left lateral decubitus position to facilitate imaging. The bed was connected to a circulating water bath set at 40°C to prevent hypothermia. The actual bed temperature was maintained at 38°C throughout the experiment, and every effort was made to maintain constant temperature, but the application of gel for echocardiography was an unavoidable variable. Transthoracic echocardiography was performed three times during the experiment. Baseline recordings were obtained at 8 wk of age, after 4 wk with PTU treatment (as described, at 12 wk of age), and after 4 wk of L-T4 treatment (as described, at 16 wk of age).
Data acquisition. Cardiac ultrasound imaging was performed using a high-frequency 15-MHz linear transducer (Sonos 5500; Agilent, Andover, MA) at a maximum frame rate of 120 frames/s. Parasternal long-and short-axis views were obtained after adjusting gain settings for optimal epicardial and endocardial wall visualization. From the shortaxis view, left ventricular (LV) M-mode tracings were obtained. From an unconventional, more superior parasternal long-axis view, ascending aortic two-dimensionally targeted M-modes were recorded. Ascending aortic pulse wave Doppler velocities were obtained from the suprasternal window by means of a pediatric short focal length, 12-MHz phased array transducer (Sonos 5500; Agilent Technologies). To improve image quality, an acoustic coupling gel standoff was mounted to the probe. This resulted in a 1-to 1.5-cm standoff between the transducer and the chest wall, enabling the transducer to work at its ideal focal length. To further improve quality by decreasing artifacts, the gel (Aquasonic 100; Parker, Orange, NJ) was centrifuged at 2,000 g to remove air bubbles.
Echocardiographic loops of Ն20 cardiac cycles containing the two-dimensional data, M-mode tracings, and Doppler velocity panels were stored digitally on magneto-optical disk for off-line analysis.
Measurements. From the short-axis view, epicardial and endocardial LV areas were measured offline at end systole and end diastole. Images were considered adequate for measurement when Ͼ75% of the epicardial and endocardial contour could be adequately visualized. In accordance with American Society of Echocardiography recommendations, the short-axis endocardial border was traced on the innermost endocardial edge, whereas the epicardial border was traced along the first bright pixel immediately adjacent to the darker myocardium (Fig. 1B) . The LV length, defined as the distance between the apex and the midmitral annulus, was obtained from the parasternal long-axis views in which the mitral annular plane and the apex were well defined (Fig.  1A) . LV measurements were made from at least three cardiac cycles, at both end systole and end diastole.
LV mass was calculated using the formula 2-D area-length method LV mass
where 1.05 is the specific gravity of muscle, A1 and A2 are the epicardial and endocardial parasternal short-axis area, respectively, L is the parasternal long-axis length, and t is the wall thickness calculated from A 1 and A2 (Fig. 1) .
Two-dimensionally targeted M-mode echocardiographic images were obtained at the level of the papillary muscles from the parasternal short-axis view and recorded at a speed of 150 cm/s (Fig. 2) . LV internal diameters and wall thickness (leading edge to trailing edge) were obtained at end systole and end diastole from cross-sectional short-axis views. Heart rate was measured, and shortening fraction (SF), the echocardiographic equivalent of ejection fraction, was calculated from these tracings by using the formula
where LVedd and LVeds are the LV internal diameter at end diastole and end systole, respectively.
For both two-dimensional and M-mode calculations, LV end-diastolic measurements were obtained at the peak of the R wave, whereas end-systolic measurements were obtained at the time of minimal chamber area.
Aortic stroke volume (SV ao) was calculated from pulse wave aortic Doppler recordings and measurements of the proximal ascending aortic diameter (Fig. 3) . Because of the pulsatile nature of the cardiovascular system, velocities are not constant throughout the cardiac cycle, thereby requiring temporal integration of the Doppler velocities known as the time velocity integral (TVI). The cross-sectional area of the aorta (CSA ao) was calculated assuming a constant circular orifice throughout the cardiac systole by use of the formula 
RESULTS

Thyroid function tests and body weights.
The thyroid function tests before and after treatment with PTU and L-T 4 are shown in Table 1 . Determination of the effect of TH on heart physiology could not be done with baseline measurements alone, because the mice had different serum concentrations of T 4 and TSH. Therefore, mice of all genotypes were made deficient in TH by PTU treatment for 4 wk. This treatment normalized the serum T 4 levels to Ͻ0.02 g/dl in all groups, whereas the TSH concentration increased 340-, 48-, and 149-fold in the wild-type, TR␣ 0/0 , and TR␤ Ϫ/Ϫ mice, respectively. L-T 4 treatment suppressed the TSH in all genotypes to Ͻ20 mU/l, whereas serum T 4 levels were similar in wild-type and TR␣ 0/0 mice, TR␤ Ϫ/Ϫ mice had slightly higher concentrations.
At baseline, TR␤ Ϫ/Ϫ mice had markedly elevated serum T 4 and TSH, consistent with their state of resistance to TH. Four-week treatment with PTU resulted in a decrease of serum T 4 levels below the limit of detection with a concomitant increase in TSH. In the TR␣ 0/0 mice, the serum TSH did not reach the level attained in the wild-type or TR␤ Ϫ/Ϫ mice. Treatment with L-T 4 suppressed the TSH in all mice, and although the serum T 4 concentration attained in the TR␤ Ϫ/Ϫ mice was not different from that in wild-type mice, it was slightly higher in the TR␣ 0/0 mice (P Ͻ 0.05). There were no significant differences in body weight at baseline for any of the three genotypes. Mice treated with PTU for 4 wk did not gain weight during this time. However, after 4 wk of L-T 4 treatment, body weight increased by 26, 13, and 32% in wild-type, TR␣ 0/0 , and TR␤ Ϫ/Ϫ mice, respectively, compared with baseline weights.
Effect of TH on heart rate. Heart rate in these mice determined during the echocardiograph analysis demonstrated resting tachycardia in untreated TR␤ Ϫ/Ϫ mice (415 Ϯ 10 beats/min) relative to the untreated wild-type mice (372 Ϯ 10 beats/min) and TR␣ 0/0 mice (407 Ϯ 10), likely reflective of the higher baseline T 4 levels in these mice. The difference in basal heart rate between wild-type and TR␣ 0/0 mice was not significant. During TH deprivation, heart rates significantly decreased in both wild-type (49 Ϯ 6%) and TR␤ Ϫ/Ϫ (39 Ϯ 6%) mice and changed only a small amount in the TR␣ 0/0 mice (5 Ϯ 6%). Although TH treatment resulted in an increase in the wild-type mice (43 Ϯ 6%), there was only minimal change in the TR␤ Ϫ/Ϫ (5 Ϯ 2%), yet a moderate increase in the TR␣ 0/0 (21 Ϯ 6%) compared with wild-type mice (Fig. 4) .
Echocardiographic analyses. The SF, equivalent to the ejection fraction, was significantly reduced in the hypothyroid wild-type mice (25.6 Ϯ 2.3%) compared with pretreatment baseline (38.4 Ϯ 2.3). Although there was a trend toward having decreased SF in TR␤ Ϫ/Ϫ and TR␣ 0/0 mice, it was not significantly different from that of wild-type mice (Fig. 5, A-C ). There were no significant changes in SF with L-T 4 treatment in the different groups compared with baseline or compared with the hypothyroid state. Preload CO (Fig. 5 , D-F) and CI (Fig. 5, G-I ) decreased by 31 Ϯ 8% and Values are means Ϯ SD; n ϭ 10. TSH, thyroid-stimulating hormone; T4, thyroxine; PTU, 5-propyl-2-thiouracil; TR␤ Ϫ/Ϫ , homozygous for disruption of thyroid hormone receptor (TR)␤; TR 0/0 , homozygous for disruption of TR␣. *P Ͻ 0.001 compared with wild type; † P Ͻ 0.05 compared with baseline, same genotype. 33 Ϯ 10%, respectively, in hypothyroid mice and increased by 69 Ϯ 10% and 35 Ϯ 8%, respectively, in hyperthyroid wild-type mice. Neither the TR␤ Ϫ/Ϫ nor the TR␣ 0/0 mice had a response in CO or CI to TH deprivation, and although the TR␣ 0/0 mice had a slight increase in CI and CO in response to TH treatment, it was not as robust as that seen in the wild-type mice (Fig. 5) .
Effect of TH on LV mass. LV mass was determined by area-to length-based estimates via transthoracic echocardiographic measurements in diastole (ALd) and systole (ALs). Although there was no significant difference in LV mass between baseline and hypothyroid mice in any genotype, L-T4 treatment resulted in an increase in the ALd of wild-type (0.079 Ϯ 0.001 to 0.126 Ϯ 0.016 g, P Ͻ 0.05) and TR␣ 0/0 mice (0.079 Ϯ 0.012 to 0.114 Ϯ 0.021 g, P Ͻ 0.05) but less so in the TR␤ Ϫ/Ϫ mice (0.085 Ϯ 0.011 to 0.089 Ϯ 0.009 g, P Ͼ 0.05) (Fig. 6) . Similar changes were seen in ALs and in ALs index and ALd index when corrected for body weight. At autopsy, upon completion of the L-T4 treatment arm of the experiment the LV weight (mg) per gram of mouse correlated with the echocardiographic measurements (3.9 vs. 4.2 mg/g, respectively, for the wild-type mice; 3.4 vs. 3.5 mg/g, respectively, for the TR␤ Ϫ/Ϫ mice; and 4.0 vs. 4.0 mg/g, respectively, for the TR␣ 0/0 mice.)
DISCUSSION
The effect of TH on the heart is both intrinsic and extrinsic. Studies demonstrating effects of TH on isolated cardiac muscle (19, 34) or perfused intact hearts (37) give insight into the intrinsic effects of TH on cardiac function, but noninvasive assessment of cardiovascular function has not been well reported in vivo. Technological advances, such as smaller probes and the creation of high-frequency linear transducers, have allowed accurate echocardiographic analysis of small mice and enabled one to obtain in vivo measurements of cardiac function (8, 11, (13) (14) (15) 36) . Echocardiographic measurements can accurately determine dynamic changes in LV mass (8) . Furthermore, studies using mice with deletion of either of the TRs allows one to delineate their contribution to TH action. This study demonstrates the role that TR␤ and TR␣ play in TH action in the heart. Whereas TR␣ 1 and TR␣ 2 are the major TR isoforms expressed in the heart, it is not surprising that wild-type and TR␤ Ϫ/Ϫ mice had a decreased heart rate in response to TH deprivation, whereas the TR␣ 0/0 mice were unresponsive (32, 48) . Whereas all three genotypes demonstrated an increase in heart rate in response to TH treatment, there was a blunted response in both the TR␣ 0/0 and TR␤ Ϫ/Ϫ mice, indicating that TR␤ also plays a role in the increase in heart rate associated with TH treatment. This study does not indicate whether the TR␤ responsiveness is a direct effect on the heart or an indirect effect on sympathomimetic factors, which, in turn, increase heart rate.
Contrary to the heart rate data presented in this paper, two previous reports, including one from our laboratory (19, 32) , have demonstrated baseline bradycardia in the TR␣ 0/0 mice. Variables that may account for this discrepancy include 1) the method of anesthesia, 2) the number of mice analyzed, and 3) the body temperature of the animal at the time of analyses. Although Gloss et al. (19) used a ketamine-xylazine cocktail, Macchia et al. (32) used chloral hydrate as we did in the present report. Although Gloss et al. analyzed six animals and reported a difference in heart rate, Macchia et al. required 43 wild-type mice to show significant differences, due to the variability in heart rate. Furthermore, our measurement of heart rate was done during simultaneous echocardiograph analysis, and although every effort was attempted to maintain euthermia in the mice, there may have been differences in body temperature to account for the differences in heart rate at baseline. TR␣ 1 knockout mice had an average heart rate 20% lower than that of wild-type mice, with prolonged QRS and QT durations at baseline and with TH treatment, suggesting that TR␤ can also affect heart rate (49) . Transgenic mice with myocardium-specific expression of a mutant TR␤ (⌬377T) demonstrated heart failure in vitro but not in vivo, suggesting that diminished performance in these mice may be compensated for by other mechanisms in vivo (38) .
Change in %SF was limited to the wild-type mice. Although there was a trend toward the TR␤ Ϫ/Ϫ mice having decreased %SF with TH deprivation and an increase with TH treatment, this did not reach significance. Furthermore, CO and CI were increased in response to TH treatment and were decreased in response to TH withdrawal in the wild-type mice, and these changes were blunted in the both the TR␤ Ϫ/Ϫ and TR␣ 0/0 mice. Therefore, whereas TR␣ seems to be more important than TR␤ for the chronotropic effects of TH on cardiac function, both TR␣ and TR␤ are necessary for the ionotropic effects. In humans, hyperthyroidism results in an increase in echocardiograhic indexes of myocardial contractility (12, 39) . Whereas normal CO in humans is 4.0-6.0 l/min, it is Ͼ7.0 and Ͻ4.0 l/min in hyperthyroid and hypothyroid humans, respectively.
Hyperthyroidism has been reported to result in increased cardiac mass in both humans (7) and mice (4, 26) . The mechanism of increased cardiac mass may be related to the local activation of the renin-angiotensin system in the heart in response to TH that can be reversed with angiotensin-converting enzyme inhibitors (1, 3, 29) . In addition, the TH-induced increase in heart size may be due, in part, to coordinated capillary and myocardial growth that is TH dependent (6, 9, 47) . The absence of TR␤ prevented the TH-mediated increase in cardiac mass, whereas the absence of TR␣ did not. TR␤ may be the important TR for the generation of tissue angiotensin-converting enzyme. In our mice, the absolute T 4 concentrations were higher in the TR␤ Ϫ/Ϫ mice compared with the TR␣ 0/0 mice only. This difference may partially account for the increase in LV mass seen in TR␤ Ϫ/Ϫ mice but cannot explain the difference compared with wild-type mice.
TR␣ is the predominant isoform in the heart. We have shown that TR␣ is required for the changes in heart rate seen with TH deprivation or treatment. However, the TH-induced increase in cardiac mass is TR␤ dependent. Taken together, these data suggest that TR␣ and TR␤ play different roles in the physiology of TH action on the heart. Furthermore, TR␤ may play a more important role in indirect effect of TH on the heart.
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